FV Pharma International (FVPI) 10-Q 2015 Q3 Quarterly report

Exhibit 32.1

Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of FV Pharma International Corp. (the “Company”) on Form 10-Q for the period ended October 31, 2014 as filed with the Securities and Exchange Commission (the “Report”), I, Shaikh M. Shami, certify pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:	February 12, 2015
By:	/s/ Shaikh M. Shami
	Shaikh M. Shami
	President, Chief Executive Officer, Chief Financial Officer,  Chief Accounting Officer, Secretary, Treasurer, Director